Mobile Investor

 Stock Information
CLDX (NASDAQ)
Last Price: 0.79
Last Trade: 4:00 PM ET - Apr 26, 2018
Change: 0.04 up  (5.61%)
Open: 0.75
Close: 0.75
High: 0.81
Low: 0.74
52-Week High: 3.42
52-Week Low: 0.65
Volume: 6,229,809
Stock price graph
 Recent News
Apr 20, 2018
Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018
Apr 16, 2018
Celldex's METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
Mar 7, 2018
Celldex Provides Corporate Update and Reports Full Year 2017 Results
Mar 2, 2018
Celldex to Report Fourth Quarter and Year-End 2017 Business/Financial Results and Present at Upcoming Investor Conference
Nov 30, 2017
Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors
 Events & Presentations
Mar 4, 2015 - 8:40 AM ET
Cowen and Company 35th Annual Health Care Conference
Feb 24, 2015 - 8:00 AM ET
Celldex Therapeutics 2014 Year End Financial Results
Feb 12, 2015 - 10:20 AM ET
2015 Leerink Global Healthcare Conference
Nov 4, 2014 - 4:00 PM
Celldex Therapeutics Third Quarter Business and Financial Highlights Press Release Issued
Sep 8, 2014 - 1:25 PM ET
Morgan Stanley Healthcare Conference
 Financial Filings
Apr 19, 2018
Form PRE 14A - Celldex Therapeutics, Inc.
Mar 7, 2018
Form 10-K - Celldex Therapeutics, Inc.
Nov 7, 2017
Form 10-Q - Celldex Therapeutics, Inc.
Aug 8, 2017
Form 10-Q - Celldex Therapeutics, Inc.
May 9, 2017
Form 10-Q - Celldex Therapeutics, Inc.
Apr 28, 2017
Form DEF 14A - Celldex Therapeutics, Inc.
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2018 Celldex Therapeutics, Inc.